Real estate
Souderton, PA, U.S., 28 January 2020 – Almac Clinical Services, part of the global contract pharmaceutical development and manufacturing organization the Almac Group, is delighted to invite participants from the Pharma & Biotech industries to join its West Coast Lunch and Learn Workshop Series.
Piramal Enterprises Limited’s Pharma Solutions business, a leading Contract Development and Manufacturing Organization, announced plans to expand its Aurora facility in Canada with the addition of a new state-of-the-art wing dedicated to manufacturing Active Pharmaceutical Ingredients.
Krystal Biotech and Foghorn Therapeutics are beginning 2020 with significant expansion projects.
All three companies have invested millions in the facilities to expand their global footprint.
Global reach extended to major pharma market in Oceania
Evotec SE announced that the wholly-owned Seattle-based company Just - Evotec Biologics initiated the construction of a late-stage clinical and commercial manufacturing facility for biologics in Redmond, Washington.
“We are excited to sign this acquisition agreement with Bayer, allowing us to have quick access to high-quality drug product manufacturing capacities and capabilities,” said Chris Chen, chief executive officer of WuXi Biologics.
Expansion makes the company one of the few in Europe capable of meeting Brexit-related demand for clients doing business in the EU
The risk-free clinical trials marketplace meets the needs of international global pharmaceuticals and sponsors by expanding the patient pool for all studies
The start of 2020 has also brought the need for some companies in the pharma industry to acquire the next size up in building space as they expand their employee headcount.
PRESS RELEASES